JPS6249279B2 - - Google Patents

Info

Publication number
JPS6249279B2
JPS6249279B2 JP60245752A JP24575285A JPS6249279B2 JP S6249279 B2 JPS6249279 B2 JP S6249279B2 JP 60245752 A JP60245752 A JP 60245752A JP 24575285 A JP24575285 A JP 24575285A JP S6249279 B2 JPS6249279 B2 JP S6249279B2
Authority
JP
Japan
Prior art keywords
formula
acetone
ppm
plants
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP60245752A
Other languages
Japanese (ja)
Other versions
JPS61112090A (en
Inventor
Itsuo Nishioka
Genichiro Nonaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP60245752A priority Critical patent/JPS61112090A/en
Publication of JPS61112090A publication Critical patent/JPS61112090A/en
Publication of JPS6249279B2 publication Critical patent/JPS6249279B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は医薬品として有用な新規タンニン及び
その製造法に関する。 タンニンは広く植物界に分布し、収斂作用のあ
ることが古くから知られ、収斂薬として、また皮
を革に変化させるなめし剤として多く用いられて
きた。 タンニンは分子量600〜2000ほどの植物の微量
成分で複雑な構造を有しており、単離精製の困難
さとあいまつて研究が遅れていた。 一方、従来より、地楡等の植物が、酵素阻害作
用等に基づく有用な医薬的効果を有することが知
られていた。 本発明者らは、これらの植物の薬効成分を検索
する目的でこれらに含まれる成分を単離取得して
薬理効果を調べた結果、幸運にも新規なるタンニ
ンに酵素阻害作用のあることを見出し本発明を完
成した。 本発明に係る化合物は、体中酵素蛋白と結合す
ることによつてその活性を低下させる作用を有し
ている。 本発明に係る化合物は、地楡、ウラジロガシ、
桂皮、キナ皮、メヒルギ、栗樹皮等の植物から、
アセトンによる抽出、酢酸エチル:水の分配、あ
るいはカラムクロマト等の公知の方法により容易
に得ることができる。 これらの方法を総括して示せば、例えば次のよ
うである。
The present invention relates to a novel tannin useful as a pharmaceutical and a method for producing the same. Tannins are widely distributed in the plant kingdom, and have long been known to have astringent effects, and have been widely used as an astringent and as a tanning agent to transform hides into leather. Tannin is a trace component of plants with a molecular weight of about 600 to 2,000, and has a complex structure, which, combined with the difficulty of isolation and purification, has delayed research. On the other hand, it has been conventionally known that plants such as elms have useful medicinal effects based on enzyme inhibitory effects and the like. In order to search for medicinal components in these plants, the present inventors isolated and obtained the components contained in these plants and investigated their pharmacological effects, and luckily discovered that a new tannin has an enzyme-inhibiting effect. The invention has been completed. The compound according to the present invention has the effect of reducing the activity of enzyme proteins in the body by binding to them. The compound according to the present invention includes elm, elm,
From plants such as cinnamon bark, cinchona bark, cane bark, chestnut bark, etc.
It can be easily obtained by known methods such as extraction with acetone, partitioning between ethyl acetate and water, or column chromatography. These methods can be summarized as follows, for example.

【表】 以下実施例を掲げて説明する。 実施例 栗樹皮2.13Kgを水性アセトン5で抽出し、水
溶液を酢酸エチル1で分液を10回繰り返した。 酢酸エチル層を集め、Sephadex LH−20でカ
ラムクロマト分離を繰り返して精製したところ、
以下の物質を得た。 compd (収率0.003%)黄かつ色無
定形粉末 〔α〕D+19.9゜ PMR(acetone−d6)ppm:5.20、5.28(1H in
total、each s、αC1−H)、7.12、7.16
(2H in total、s、galloyl−H) CMR(acetone−d6)ppm:63.8(C2′αβ)、
64.9(C5−α)、66.6(C5−β)、71.5(C3
−α)72.9(C3−β)、78.5(C2−α)、79.9
(C4−α)、80.7(C2−β、C4−β)、98.2
(Cl−α)、103.0(Cl−β)、110.0
[Table] Examples will be described below. Example 2.13 kg of chestnut bark was extracted with 5 parts of aqueous acetone, and the aqueous solution was separated with 1 part of ethyl acetate 10 times. The ethyl acetate layer was collected and purified by repeated column chromatography separation using Sephadex LH-20.
The following substances were obtained. compd (Yield 0.003%) Yellow and colored amorphous powder [α] D +19.9゜ PMR (acetone−d 6 ) ppm: 5.20, 5.28 (1H in
total, each s, αC1−H), 7.12, 7.16
(2H in total, s, galloyl-H) CMR (acetone-d 6 ) ppm: 63.8 (C2′αβ),
64.9 (C5−α), 66.6 (C5−β), 71.5 (C3
−α) 72.9 (C3−β), 78.5 (C2−α), 79.9
(C4−α), 80.7 (C2−β, C4−β), 98.2
(Cl−α), 103.0 (Cl−β), 110.0

【式】 121.2【formula】 121.2

【式】 139.0【formula】 139.0

【式】 146.0【formula】 146.0

【式】 167.3(C=0) compd (収率0.006%)無色結晶
〔α〕D−60.0゜ PMR(acetone−d6)ppm:6.44(1H、s、Cl
−H)、7.08、7.10、7.12(each 2H、s、
galloyl−H) CMR(acetone−d6)ppm:67.0(C5、C2′)、
74.1(C3)80.4(C2)、82.5(C4)、100.6
(C1)、110.0
[Formula] 167.3 (C=0) compd (Yield 0.006%) Colorless crystal [α] D −60.0゜ PMR (acetone−d 6 ) ppm: 6.44 (1H, s, Cl
-H), 7.08, 7.10, 7.12 (each 2H, s,
galloyl-H) CMR (acetone-d 6 ) ppm: 67.0 (C5, C2′),
74.1 (C3) 80.4 (C2), 82.5 (C4), 100.6
(C1), 110.0

【式】 120.9【formula】 120.9

【式】 139.2【formula】 139.2

【式】 146.0【formula】 146.0

【式】 165.7、167.2、167.3、(C=0) compd (収率0.00065%)無色針状
結晶〔α〕D−47.7゜、mp>290℃ PMR(acetone−d6)ppm:5.65(d、J=8
Hz、C3−H)、6.60(1H、s、C1−H)、
7.08、7.16、7.24、7.28(each 2H、s、
galloy−H)
[Formula] 165.7, 167.2, 167.3, (C=0) compd (Yield 0.00065%) Colorless needle crystals [α] D -47.7°, mp>290℃ PMR (acetone-d 6 ) ppm: 5.65 (d, J=8
Hz, C3-H), 6.60 (1H, s, C1-H),
7.08, 7.16, 7.24, 7.28 (each 2H, s,
galloy-H)

Claims (1)

【特許請求の範囲】 1 次の一般式〔〕 〔R51、R52、R53、R54、R55は、同一又は異なつ
て、水素又はG(Gはgalloyl基
【式】を示す。)を示す。ただし、 R51、R52、R53、R54、R55が同時に水素である場
合を除く。また、R52、R54、R55が同時にGでか
つR51、R53がともに水素である場合を除く。〕で
表わされる新規なタンニン。
[Claims] First-order general formula [] [R 51 , R 52 , R 53 , R 54 , and R 55 are the same or different and represent hydrogen or G (G represents a galloyl group [Formula]). However, this excludes the case where R 51 , R 52 , R 53 , R 54 , and R 55 are hydrogen at the same time. Further, the case where R 52 , R 54 and R 55 are G at the same time and R 51 and R 53 are both hydrogen is excluded. ] A new tannin represented by
JP60245752A 1985-10-31 1985-10-31 Novel tannin Granted JPS61112090A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60245752A JPS61112090A (en) 1985-10-31 1985-10-31 Novel tannin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60245752A JPS61112090A (en) 1985-10-31 1985-10-31 Novel tannin

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP57170013A Division JPS5959638A (en) 1982-09-28 1982-09-28 Novel tannin

Publications (2)

Publication Number Publication Date
JPS61112090A JPS61112090A (en) 1986-05-30
JPS6249279B2 true JPS6249279B2 (en) 1987-10-19

Family

ID=17138267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60245752A Granted JPS61112090A (en) 1985-10-31 1985-10-31 Novel tannin

Country Status (1)

Country Link
JP (1) JPS61112090A (en)

Also Published As

Publication number Publication date
JPS61112090A (en) 1986-05-30

Similar Documents

Publication Publication Date Title
US4210581A (en) Organic compounds
US4108985A (en) Dihydrocyclosporin c
US10160780B2 (en) Compound extracted from husk and fruit stem of Xanthoceras sobifolia and its extracting method and use thereof
RU2387656C2 (en) Method for synthesis of galantamine hydrobromide
JPS6222990B2 (en)
NO863329L (en) PHARMACOLOGICAL EFFECT.
JPH0229078B2 (en)
EP0036663A1 (en) Oxiranebutanoic acid derivatives, their preparation and use, and medicaments containing them
EP0185740A1 (en) Epipodophyllotoxinquinone glucoside derivatives method of production and use.
Friess et al. Further Observations on the Reaction of Cyclanones with Perbenzoic Acid
JPS62142181A (en) Novel tannin
JPH0231074B2 (en) SHINTANNIN
US5441932A (en) Sugar compounds for inhibition of the biosynthesis of sugar chains containing sialic acid
SE437829B (en) SET TO INSULATE ALKALOID COMPONENTS FROM VINCA ROSEA L
JPS6249279B2 (en)
JPS6353993B2 (en)
JPS6136826B2 (en)
JPH0246598B2 (en) SHINKINARUTANNIN
JPS6249277B2 (en)
JPH0160475B2 (en)
JPS61112089A (en) Novel tannin
JPS6084220A (en) Antitumor agent containing phizoxin which is metabolite of plant pathogenic germ phizopus chinensis
JPH0225909B2 (en)
JP3435692B2 (en) Sheatan derivative
US2970159A (en) Hydrazine derivatives